DIKER MANAGEMENT LLC - ANIKA THERAPEUTICS INC ownership

ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 118 filers reported holding ANIKA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.1%.

Quarter-by-quarter ownership
DIKER MANAGEMENT LLC ownership history of ANIKA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$935,953
+16.4%
50,239
+62.4%
0.84%
+24.0%
Q2 2023$803,795
-15.9%
30,939
-7.1%
0.67%
-32.3%
Q1 2023$956,060
+43.8%
33,289
+48.2%
1.00%
+29.9%
Q4 2022$664,757
+24.3%
22,4580.0%0.77%
+11.3%
Q3 2022$535,000
+9.9%
22,458
+2.9%
0.69%
+14.6%
Q2 2022$487,000
-11.1%
21,8350.0%0.60%
+36.0%
Q1 2022$548,000
-29.9%
21,8350.0%0.44%
-17.4%
Q4 2021$782,000
-15.8%
21,8350.0%0.54%
+11.9%
Q3 2021$929,000
-1.7%
21,8350.0%0.48%
+15.2%
Q2 2021$945,000
+6.1%
21,8350.0%0.42%
-0.7%
Q1 2021$891,000
-9.8%
21,8350.0%0.42%
-16.4%
Q4 2020$988,000
+27.8%
21,8350.0%0.50%
+3.7%
Q3 2020$773,000
-6.2%
21,8350.0%0.48%
-19.4%
Q2 2020$824,000
+30.0%
21,835
-0.5%
0.60%
+123.1%
Q1 2020$634,000
-40.6%
21,935
+6.6%
0.27%
-61.2%
Q4 2019$1,067,000
-36.5%
20,582
-32.7%
0.69%
-36.9%
Q3 2019$1,679,000
+35.2%
30,5870.0%1.10%
+111.4%
Q2 2019$1,242,000
+14.2%
30,587
-15.0%
0.52%
-21.9%
Q1 2019$1,088,000
-7.4%
35,987
+3.0%
0.66%
+34.2%
Q4 2018$1,175,000
-20.3%
34,9550.0%0.49%
-5.7%
Q3 2018$1,474,000
+38.1%
34,955
+4.8%
0.52%
+37.2%
Q2 2018$1,067,000
-34.7%
33,355
+1.5%
0.38%
-30.3%
Q1 2018$1,634,000
-7.7%
32,8550.0%0.55%
-14.0%
Q4 2017$1,771,000
-4.2%
32,855
+3.1%
0.64%
-14.4%
Q3 2017$1,848,000
+17.6%
31,8550.0%0.74%
+6.6%
Q2 2017$1,572,000
+13.6%
31,8550.0%0.70%
+9.1%
Q1 2017$1,384,000
-11.3%
31,8550.0%0.64%
-3.8%
Q4 2016$1,560,000
-6.0%
31,855
-8.1%
0.66%
+12.5%
Q3 2016$1,659,000
-8.9%
34,665
+2.1%
0.59%
-16.6%
Q2 2016$1,822,000
+23.6%
33,965
+3.0%
0.71%
+26.6%
Q1 2016$1,474,000
+15.3%
32,965
-1.5%
0.56%
+56.9%
Q4 2015$1,278,000
+29.6%
33,480
+8.1%
0.36%
+63.8%
Q3 2015$986,000
+46.1%
30,980
+51.6%
0.22%
+84.7%
Q2 2015$675,000
-17.8%
20,430
+2.4%
0.12%
-20.3%
Q1 2015$821,000
-7.0%
19,950
-8.0%
0.15%
-14.0%
Q4 2014$883,000
+9.7%
21,685
-1.2%
0.17%
+10.3%
Q3 2014$805,000
-18.0%
21,950
+3.5%
0.16%
-27.4%
Q2 2014$982,000
+2.9%
21,200
-8.6%
0.22%
+3.9%
Q1 2014$954,000
+3.4%
23,200
-4.1%
0.21%
-2.4%
Q4 2013$923,000
+65.1%
24,200
+3.4%
0.21%
+49.3%
Q3 2013$559,000
-0.4%
23,400
-29.1%
0.14%
-17.9%
Q2 2013$561,00033,0000.17%
Other shareholders
ANIKA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Euclidean Technologies Management, LLC 44,875$2,031,0002.14%
Parian Global Management LP 102,705$4,648,0001.16%
CAPITAL MANAGEMENT CORP /VA 93,035$4,211,0001.15%
Avidity Partners Management LP 731,000$33,085,0001.07%
Sio Capital Management, LLC 65,382$2,959,0000.61%
DIKER MANAGEMENT LLC 21,835$988,0000.50%
Archon Capital Management LLC 48,925$2,214,0000.38%
Caption Management, LLC 362,800$16,420,0000.37%
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC 1,546,260$69,984,0000.20%
Boston Trust Walden Corp 378,167$17,116,0000.18%
View complete list of ANIKA THERAPEUTICS INC shareholders